Giordano Douglas E.
SEC-identified person · CIK 1431552 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Director | filed 2026 - 2026 |
| Cerevel Therapeutics Holdings, Inc. CERF | Director | filed 2020 - 2024 |
| Panacea Acquisition Corp. II PANA | Director | filed 2021 - 2021 |
| Viatris Inc VTRS | Director | filed 2020 - 2020 |
| ICU Medical INC/DE ICUI | Director | filed 2017 - 2017 |
| Zoetis Inc. ZTS | Director | filed 2013 - 2013 |
| Icagen INC ICGN | Director | filed 2011 - 2011 |
| King Pharmaceuticals INC KG | Director | filed 2011 - 2011 |
| Encysive Pharmaceuticals INC ENCY | Director | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.